ClinicalTrials.govpublic full text
Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
sars-cov infection, coronavirus, angiotensin receptor blocker, sars-cov-2, covid-19, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.